BackRapport Therapeutics Overview

Rapport Therapeutics Receivables

Track Rapport Therapeutics's receivables ($290K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$293000.00

Peer trimmed avg / median

Loading

Rapport Therapeutics Receivables History

Loading

Rapport Therapeutics vs. peers: Receivables Comparison

Loading

Rapport Therapeutics Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Rapport Therapeutics (RAPP) FAQ

Rapport Therapeutics (RAPP) currently reports a receivables of $290K as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Rapport Therapeutics's receivables history and peer comparisons.

Rapport Therapeutics's receivables changed from $0 to $290K (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Rapport Therapeutics reported $290K in receivables as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $290K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Rapport Therapeutics, and consider following RAPP for alerts when major investors trade the stock.